Loading patent…
AssigneeGreen Cross Wellbeing Corporation
InventorsMinjung Jang, Gyeongeun Hong, Gideok Park, Jaeyoung Kim, Hyunsu Kim, Yongpil Hwang
Estimating the term…
Novel strains of Lactobacillus plantarum GCWB1001 deposited as accession number KCCM12698P, Pediococcus acidilactici GCWB1085 deposited as accession number KCCM12699P, or Lactobacillus rhamnosus GCWB1156 deposited as accession number KCCM12700P are disclosed. The novel strains have the excellent effect of treating or alleviating respiratory diseases. Additionally, provided are a pharmaceutical composition, a health functional food composition, and probiotics, all of which have the effect of treating or alleviating inflammatory diseases or respiratory diseases, containing any one of the novel strains.
A method for treating an inflammatory disease or a respiratory disease in a subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a Lactobacillus plantarum GCWB1001 strain deposited as accession number KCCM12698P, wherein the pharmaceutical composition is selected from the group consisting of spray-dried strain, freeze-dried strain, vacuum dried strain, drum dried strain, crushed strain, a culture of the strain, a concentrate of the culture, a paste of the culture, a dilution of the culture, and a combination thereof.
A method for alleviating an inflammatory disease or a respiratory disease in a subject in need thereof, comprising administering to the subject a probiotic composition comprising a Lactobacillus plantarum GCWB1001 strain deposited as accession number KCCM12698P.
Dependencies are inferred from the claim text.